BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16679722)

  • 1. Protective effect of botulinum C/D mosaic toxoid against avian botulism.
    Takeda M; Kasai H; Torii Y; Mukamoto M; Kohda T; Tsukamoto K; Kozaki S
    J Vet Med Sci; 2006 Apr; 68(4):325-30. PubMed ID: 16679722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective potential of recombinant non-purified botulinum neurotoxin serotypes C and D.
    Moreira C; da Cunha CE; Moreira GM; Mendonça M; Salvarani FM; Moreira ÂN; Conceição FR
    Anaerobe; 2016 Aug; 40():58-62. PubMed ID: 27236078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective efficacy of recombinant bacterin vaccine against botulism in cattle.
    Moreira C; Ferreira MRA; Finger PF; Magalhães CG; Cunha CEP; Rodrigues RR; Otaka DY; Galvão CC; Salvarani FM; Moreira ÂN; Conceição FR
    Vaccine; 2020 Mar; 38(11):2519-2526. PubMed ID: 32037222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a type C botulism vaccine in green-winged teal.
    Rocke TE; Samuel MD; Swift PK; Yarris GS
    J Wildl Dis; 2000 Jul; 36(3):489-93. PubMed ID: 10941734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization of ducks for type C botulism.
    Martinez R; Wobeser G
    J Wildl Dis; 1999 Oct; 35(4):710-5. PubMed ID: 10574530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative vaccination against equine botulism (BoNT/C).
    Frey J; Eberle S; Stahl C; Mazuet C; Popoff M; Schatzmann E; Gerber V; Dungu B; Straub R
    Equine Vet J; 2007 Nov; 39(6):516-20. PubMed ID: 18065309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the neurotoxin produced by isolates associated with avian botulism.
    Takeda M; Tsukamoto K; Kohda T; Matsui M; Mukamoto M; Kozaki S
    Avian Dis; 2005 Sep; 49(3):376-81. PubMed ID: 16252491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination of cattle with a recombinant bivalent toxoid against botulism serotypes C and D.
    Cunha CE; Moreira GM; Salvarani FM; Neves MS; Lobato FC; Dellagostin OA; Conceição FR
    Vaccine; 2014 Jan; 32(2):214-6. PubMed ID: 24252701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the D/C mosaic neurotoxin produced by Clostridium botulinum associated with bovine botulism in Japan.
    Nakamura K; Kohda T; Umeda K; Yamamoto H; Mukamoto M; Kozaki S
    Vet Microbiol; 2010 Jan; 140(1-2):147-54. PubMed ID: 19720474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral Response of Buffaloes to a Recombinant Vaccine against Botulism Serotypes C and D.
    Otaka DY; Barbosa JD; Moreira C; Ferreira MRA; Cunha CEP; Brito ARS; Donassolo RA; Moreira ÂN; Conceição FR; Salvarani FM
    Toxins (Basel); 2017 Sep; 9(10):. PubMed ID: 28937601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of candidate subunit vaccine and novel antitoxin against botulinum neurotoxin serotype E.
    Shi DY; Liu FJ; Mao YY; Cui RT; Lu JS; Yu YZ; Dong XJ; Yang ZX; Sun ZW; Pang XB
    Hum Vaccin Immunother; 2020; 16(1):100-108. PubMed ID: 31210561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response of horses to vaccination with the recombinant Hc domain of botulinum neurotoxin types C and D.
    Stahl C; Unger L; Mazuet C; Popoff M; Straub R; Frey J
    Vaccine; 2009 Sep; 27(41):5661-6. PubMed ID: 19646409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of avian botulism in Korea during the period from June to September 2012.
    Jang I; Kang MS; Kim HR; Oh JY; Lee JI; Lee HS; Kwon YK
    Avian Dis; 2014 Dec; 58(4):666-9. PubMed ID: 25619016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Clostridium botulinum types C and D toxoid vaccination in Danish cows.
    Krüger M; Skau M; Shehata AA; Schrödl W
    Anaerobe; 2013 Oct; 23():97-101. PubMed ID: 23831724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentavalent replicon vaccines against botulinum neurotoxins and tetanus toxin using DNA-based Semliki Forest virus replicon vectors.
    Yu YZ; Liu S; Ma Y; Gong ZW; Wang S; Sun ZW
    Hum Vaccin Immunother; 2014; 10(7):1874-9. PubMed ID: 25424795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of protective neutralizing antibody responses against botulinum neurotoxin serotype C using plasmid carried by PLGA nanoparticles.
    Ruwona TB; Xu H; Li J; Diaz-Arévalo D; Kumar A; Zeng M; Cui Z
    Hum Vaccin Immunother; 2016 May; 12(5):1188-92. PubMed ID: 26837242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of new formalin-detoxified botulinum neurotoxin toxoids.
    Keller JE
    Clin Vaccine Immunol; 2008 Sep; 15(9):1374-9. PubMed ID: 18667637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunization of broiler chickens against type C botulism.
    Dohms JE; Allen PH; Cloud SS
    Avian Dis; 1982; 26(2):340-5. PubMed ID: 7049149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of a Bivalent Non-Purified Recombinant Vaccine against Botulism in Cattle.
    Moreira C; Ferreira MRA; da Cunha CEP; Donassolo RA; Finger PF; Moreira GMSG; Otaka DY; de Sousa LA; Barbosa JD; Moreira ÂN; Salvarani FM; Conceição FR
    Toxins (Basel); 2018 Sep; 10(10):. PubMed ID: 30241350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with recombinant whole heavy chain fragments of Clostridium botulinum Type C and D neurotoxins.
    Arimitsu H; Lee JC; Sakaguchi Y; Hayakawa Y; Hayashi M; Nakaura M; Takai H; Lin SN; Mukamoto M; Murphy T; Oguma K
    Clin Diagn Lab Immunol; 2004 May; 11(3):496-502. PubMed ID: 15138174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.